These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14673630)

  • 1. ACE inhibition in the treatment of children after renal transplantation.
    Arbeiter K; Pichler A; Stemberger R; Mueller T; Ruffingshofer D; Vargha R; Balzar E; Aufricht C
    Pediatr Nephrol; 2004 Feb; 19(2):222-6. PubMed ID: 14673630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension, antihypertensive agents and outcomes following renal transplantation.
    Tutone VK; Mark PB; Stewart GA; Tan CC; Rodger RS; Geddes CC; Jardine AG
    Clin Transplant; 2005 Apr; 19(2):181-92. PubMed ID: 15740553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.
    Formica RN; Friedman AL; Lorber MI; Bia MJ
    Transplant Proc; 2004 Nov; 36(9):2675-8. PubMed ID: 15621121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment in renal transplant patients--is there a role for ACE inhibitors?
    Hausberg M; Kosch M; Hohage H; Suwelack B; Barenbrock M; Kisters K; Rahn KH
    Ann Transplant; 2001; 6(4):31-7. PubMed ID: 12035456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation.
    Orlić L; Mikolasević I; Sladoje-Martinović B; Bubić I; Pavletić-Persić M; Racki S
    Coll Antropol; 2013 Sep; 37(3):809-14. PubMed ID: 24308221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitors and renal function.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1989 Sep; 7(5):S3-9. PubMed ID: 2681604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy.
    Stigant CE; Cohen J; Vivera M; Zaltzman JS
    Am J Kidney Dis; 2000 Jan; 35(1):58-63. PubMed ID: 10620545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function. A retrospective study.
    Mann JF; Reisch C; Ritz E
    Nephron; 1990; 55 Suppl 1():38-42. PubMed ID: 2345591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of angiotensin-converting enzyme inhibitors genotype for ACEi response in patients with chronic allograft nephropathy].
    Savin M; Petronić V
    Srp Arh Celok Lek; 2005; 133(3-4):194-8. PubMed ID: 16206711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure, antihypertensive treatment, and graft survival in kidney transplant patients.
    Hillebrand U; Suwelack BM; Loley K; Lang D; Reuter S; Amler S; Pavenstädt H; Hausberg M; Büssemaker E
    Transpl Int; 2009 Nov; 22(11):1073-80. PubMed ID: 19624495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy in renal disease and transplantation.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1992 Jul; 10(5):S79-85. PubMed ID: 1403237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control in kidney transplantation: therapeutic implications.
    Premasathian NC; Muehrer R; Brazy PC; Pirsch JD; Becker BN
    J Hum Hypertens; 2004 Dec; 18(12):871-7. PubMed ID: 15318162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prolonged angiotensin-converting enzyme inhibition on excretory kidney function and proteinuria in renal allograft recipients with chronic progressive transplant failure.
    Barnas U; Schmidt A; Haas M; Oberbauer R; Mayer G
    Nephrol Dial Transplant; 1996 Sep; 11(9):1822-4. PubMed ID: 8918629
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibition in chronic allograft nephropathy.
    Lin J; Valeri AM; Markowitz GS; D'Agati VD; Cohen DJ; Radhakrishnan J
    Transplantation; 2002 Mar; 73(5):783-8. PubMed ID: 11907428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R; Heidbreder E; Heidland A
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
    Jennings DL; Taber DJ
    Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.